Three Reasons Why Military Recruitment Is In Crisis
By the middle of 2022, it was already become apparent that the US military was having problems meeting recruitment goals. In August last year, The AP reported that the Army would have to cut force size, and an army spokesman admitted the Army was facing "'unprecedented challenges' in bringing in recruits." This came even with new larger enlistment bonuses. The problem, however, wasn't as acute for the Air Force, Navy, or Marine Corps.
Since then, things haven't gotten any better for recruiters. Now, recruitment shortfalls have spread well beyond the Army. The New York Post reported last week:
Much of the military will fall short of recruitment goals by as much as 25% this year …
The Army, Navy, Air Force, and Coast Guard are all expected to fall short of their recruitment goals this year, they told The Post. …
A spokesperson for the Air Force said they will likely miss their goal of 26,877 new recruits by 10%. The Coast Guard said they will likely only fill 75% of the number of full-time, non-commissioned recruits they need.
And as of April, the Navy, which has over 300,000 active duty personnel, was behind by 6,000 new recruits this year, and the Army by 10,000 out of their 65,000 goal.
https://www.zerohedge.com/markets/three-reasons-why-military-recruitment-crisis
The U.S. Court of Appeals for the Fifth Circuit issued a unanimous three-judge decision on September 1, 2023, holding that the Federal Drug Administration (FDA) overstepped its statutory authority by attempting to ban using ivermectin to treat COVID-19. In Apter v. Department of Health and Human Services, court concluded, “FDA is not a physician. It has authority to inform, announce, and apprise—but not to endorse, denounce, or advise.”
Fifth Circuit Rebukes FDA for Banning Ivermectin for Covid-1
Writing for the three-judge panel, Circuit Judge Don R. Willett began the court’s opinion by citing the strident nature of the FDA’s opposition to ivermectin as a COVID-19 treatment. Willett opened his opinion as follows:
“You are not a horse.”
Or so the Food and Drug Administration (“FDA”) alerted millions of Americans via social media, midway through the COVID-19 pandemic. The agency had discerned that some people were treating their symptoms using the animal version of a drug called ivermectin. FDA decided to target the practice via the “horse” message—and others like it. The messaging traveled widely across legacy and online media. Left unmentioned in most of that messaging: ivermectin also comes in a human version. And while the human version of ivermectin is not FDA-approved to treat the coronavirus, some people were using it off-label for that purpose.
https://www.americanthinker.com/articles/2023/09/fifth_circuit_rebukes_fda_for_banning_ivermectin_for_covid19.html
Chck!